Business Context and Reporting Period
This Form 8-K filing by Anthem, Inc. (now Elevance Health, Inc.) was submitted on April 24, 2019. The report serves to disclose the company's financial results for the first quarter ended March 31, 2019, via a press release furnished as Exhibit 99.1.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced press release (Exhibit 99.1) and are not explicitly detailed in the body of this 8-K document.
Material Changes
The document does not list specific material changes in financial performance compared to prior periods. It solely references the issuance of the Q1 2019 results press release.
Guidance, Outlook, and Risks
The filing includes a comprehensive "Forward-Looking Statements" section outlining significant risks and uncertainties that could cause actual results to differ from projections. Key risks identified include:
- Regulatory and Legal: Changes to the Affordable Care Act (ACA), legal challenges to the ACA, and complex regulations regarding Medicare and Medicaid programs.
- Operational and Market: Trends in healthcare costs, competitive pressures, reduced enrollment, and the ability to secure premium rates.
- Strategic Litigation: Ongoing litigation with Cigna Corporation regarding a failed merger agreement, including claims for damages and termination fees.
- Vendor and Service Risks: Potential non-compliance or transition issues with pharmacy benefit management services agreements involving Express Scripts and CVS Health.
- Financial and Reputational: Substantial outstanding indebtedness, potential downgrades in financial strength ratings, and risks related to data security and member information disclosure.
Investor Verification Checklist
- Review the full text of the Q1 2019 press release (Exhibit 99.1) for specific revenue, earnings, and cash flow figures.
- Monitor the status and potential financial impact of the litigation between Anthem and Cigna Corporation.
- Assess the progress and risks associated with the transition of pharmacy benefit management services from Express Scripts to CVS Health.
- Track regulatory developments regarding the ACA and their potential effect on premium rates and enrollment.